These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15216948)

  • 1. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in an Italian intensive care unit: clinical and therapeutical remarks.
    Carretto E; Emmi V; Barbarini D; Capra Marzani F; Bolongaro A; Braschi A; Marone P
    J Chemother; 2004 Apr; 16(2):145-50. PubMed ID: 15216948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
    Bindayna KM; Senok AC; Jamsheer AE
    J Infect Public Health; 2009; 2(3):129-35. PubMed ID: 20701872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].
    Paluchowska P; Skałkowska M; Spelak A; Budak A
    Med Dosw Mikrobiol; 2012; 64(1):35-43. PubMed ID: 22808728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae in Trakya University Hospital, Turkey.
    Akata F; Tatman-Otkun M; Ozkan E; Tansel O; Otkun M; Tugrul M
    New Microbiol; 2003 Jul; 26(3):257-62. PubMed ID: 12901421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
    Hirakata Y; Matsuda J; Miyazaki Y; Kamihira S; Kawakami S; Miyazawa Y; Ono Y; Nakazaki N; Hirata Y; Inoue M; Turnidge JD; Bell JM; Jones RN; Kohno S;
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):323-9. PubMed ID: 16165001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.
    Manzur A; Tubau F; Pujol M; Calatayud L; Dominguez MA; Peña C; Sora M; Gudiol F; Ariza J
    J Clin Microbiol; 2007 Aug; 45(8):2365-9. PubMed ID: 17581932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.
    Kola A; Holst M; Chaberny IF; Ziesing S; Suerbaum S; Gastmeier P
    J Hosp Infect; 2007 May; 66(1):46-51. PubMed ID: 17350720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon.
    Moubareck C; Daoud Z; Hakimé NI; Hamzé M; Mangeney N; Matta H; Mokhbat JE; Rohban R; Sarkis DK; Doucet-Populaire F
    J Clin Microbiol; 2005 Jul; 43(7):3309-13. PubMed ID: 16000453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of ESBL producing isolates in patients surgically treated for acute appendicitis.
    Gupta N; Sohanlal T; Soman R; Shetty A; Rodrigues C
    J Assoc Physicians India; 2011 May; 59():293-5. PubMed ID: 21751605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
    Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
    Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended spectrum beta-lactamase producing
    Prevel R; Boyer A; M'Zali F; Cockenpot T; Lasheras A; Dubois V; Gruson D
    Antimicrob Resist Infect Control; 2019; 8():112. PubMed ID: 31333839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of extended spectrum beta lactamase producing enterobacteriaceae among urinary pathogen isolates.
    Afridi FI; Farooqi BJ; Hussain A
    J Coll Physicians Surg Pak; 2011 Dec; 21(12):741-4. PubMed ID: 22166694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
    Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
    Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamase-producing organisms.
    Falagas ME; Karageorgopoulos DE
    J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.